Marksans Pharma Q3 Results

  • BSE: 524404
  • NSE: MARKSANS
  • ISIN: INE750C01026
  • Sector: Biotechnology & Drugs
BSE
315.77.15 (2.32%)
Volume83.85 K
Updated: Mon 25 Nov, 2024 | 15:40:44
NSE
315.556.90 (2.24%)
Volume1.48 M
Updated: Mon 25 Nov, 2024 | 15:44:08
Today: 310.00
318.70
52-Wk: 126.05
328.35

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Marksans Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 586.13531.24-%479.83-%
    Selling/ General/ Admin Expenses Total 74.5371.13-%62.19-%
    Depreciation/ Amortization 22.0017.55-%12.74-%
    Other Operating Expenses Total 105.7693.44-%101.51-%
    Total Operating Expense 475.11434.84-%415.93-%
    Operating Income 111.0296.40-%63.90-%
    Net Income Before Taxes 112.66113.77-%79.20-%
    Net Income 83.2383.52-%63.41-%
    Diluted Normalized EPS 1.841.84-%1.56-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts